The title of ARVO Fellow is an honor established to recognize current ARVO members for their individual accomplishments, leadership and contributions to the Association. ARVO Fellows serve as role models and mentors for individuals pursuing careers in vision and ophthalmology research and help further ARVO's vision "…to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders," which includes advancing basic and clinical knowledge and serving as the leading international forum for vision research and the primary advocate for vision science worldwide.
Mon, 12/13/2021 - 07:45Dr. Fingert is named a 2022 Gold Fellow of the Association for Research in Vision and Ophthalmology.
Mon, 08/09/2021 - 11:15
The Fingert Lab and colleagues from the Faroe Islands and Denmark conducted a prospective study of the prevalence of glaucoma on the isolated population of the Faroe Islands located in the North Atlantic. The prevalence of open angle glaucoma in citizens over 40 years of age was 1.1% and highly age-related. Glaucoma patients were tested for disease-causing variants in known glaucoma-causing genes (MYOC, OPTN, TBK1), but none were detected, suggesting that a unique set of genes may cause glaucoma on the Faroe Islands. Read more about it here.
Thu, 07/15/2021 - 14:15
The Fingert lab led a study of pigmentary glaucoma that scanned through every gene in the genomes of hundreds of patients with pigmentary glaucoma in search of disease-causing defects. The results of the study have been published in BMC genomics this month. This study identified MRAP (melanocortin 2 receptor accessory protein) as a new potential contributor to pigmentary glaucoma. It is highly produced in the iris - the source of the pigment released in the eye in pigmentary glaucoma (see photo above). Read more about this discovery here.